Zheng J, Baldi S, Zhao L, Li H, et al. Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial. Respir Res 2021;22:90.
PMID: 33757520